LEIGH HANLEY: Open Payments
NPI 1780071084 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$964 in 39 payments from 14 companies in 2025. Trend: 2023 $469 · 2024 $505 · 2025 $964
Food & beverage: $937Education: $27
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $220 |
| Fresenius USA Marketing, Inc. | 13 | $166 |
| Boston Scientific Corporation | 2 | $145 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $96 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $81 |
| Calliditas Therapeutics US Inc. | 2 | $62 |
| ANI Pharmaceuticals, Inc. | 2 | $48 |
| Aurinia Pharma U.S., Inc. | 2 | $34 |
| AKEBIA THERAPEUTICS INC | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: JYNARQUE, VELPHORO, JARDIANCE, General - EP, Kerendia, WATCHMAN FLX, TARPEYO, PURIFIED CORTROPHIN GEL.
Industry payments across VA — which companies pay providers there.
